MILIBOO SA (ALMLB.PA) Fundamental Analysis & Valuation

EPA:ALMLB • FR0013053535

Current stock price

1.76 EUR
0 (0%)
Last:

This ALMLB.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALMLB.PA Profitability Analysis

1.1 Basic Checks

  • ALMLB had negative earnings in the past year.
  • ALMLB had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ALMLB reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: ALMLB reported negative operating cash flow in multiple years.
ALMLB.PA Yearly Net Income VS EBIT VS OCF VS FCFALMLB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.61%, ALMLB is doing worse than 78.79% of the companies in the same industry.
  • With a Return On Equity value of -3.94%, ALMLB is not doing good in the industry: 78.79% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -1.61%
ROE -3.94%
ROIC N/A
ROA(3y)0.93%
ROA(5y)2.07%
ROE(3y)-1.09%
ROE(5y)23.82%
ROIC(3y)N/A
ROIC(5y)N/A
ALMLB.PA Yearly ROA, ROE, ROICALMLB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800

1.3 Margins

  • The Gross Margin of ALMLB (26.58%) is worse than 63.64% of its industry peers.
  • ALMLB's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALMLB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5Y1.16%
ALMLB.PA Yearly Profit, Operating, Gross MarginsALMLB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ALMLB.PA Health Analysis

2.1 Basic Checks

  • ALMLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALMLB remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for ALMLB has been increased compared to 5 years ago.
  • Compared to 1 year ago, ALMLB has an improved debt to assets ratio.
ALMLB.PA Yearly Shares OutstandingALMLB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
ALMLB.PA Yearly Total Debt VS Total AssetsALMLB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • An Altman-Z score of 3.47 indicates that ALMLB is not in any danger for bankruptcy at the moment.
  • ALMLB's Altman-Z score of 3.47 is amongst the best of the industry. ALMLB outperforms 81.82% of its industry peers.
  • A Debt/Equity ratio of 0.15 indicates that ALMLB is not too dependend on debt financing.
  • The Debt to Equity ratio of ALMLB (0.15) is better than 84.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 3.47
ROIC/WACCN/A
WACC7.11%
ALMLB.PA Yearly LT Debt VS Equity VS FCFALMLB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

2.3 Liquidity

  • ALMLB has a Current Ratio of 1.78. This is a normal value and indicates that ALMLB is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.78, ALMLB is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • A Quick Ratio of 0.85 indicates that ALMLB may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.85, ALMLB is in line with its industry, outperforming 57.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.85
ALMLB.PA Yearly Current Assets VS Current LiabilitesALMLB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ALMLB.PA Growth Analysis

3.1 Past

  • The earnings per share for ALMLB have decreased strongly by -110.80% in the last year.
  • The Revenue for ALMLB has decreased by -10.02% in the past year. This is quite bad
  • Measured over the past years, ALMLB shows a small growth in Revenue. The Revenue has been growing by 5.42% on average per year.
EPS 1Y (TTM)-110.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.16%
Revenue 1Y (TTM)-10.02%
Revenue growth 3Y-0.18%
Revenue growth 5Y5.42%
Sales Q2Q%-7.29%

3.2 Future

  • ALMLB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -31.83% yearly.
  • The Revenue is expected to decrease by -8.53% on average over the next years.
EPS Next Y17.64%
EPS Next 2Y0.93%
EPS Next 3Y-31.83%
EPS Next 5YN/A
Revenue Next Year-8.57%
Revenue Next 2Y-6.23%
Revenue Next 3Y-8.53%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALMLB.PA Yearly Revenue VS EstimatesALMLB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M 50M
ALMLB.PA Yearly EPS VS EstimatesALMLB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 -0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALMLB.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALMLB. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 5.64, which indicates a rather cheap valuation of ALMLB.
  • 87.88% of the companies in the same industry are more expensive than ALMLB, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.79. ALMLB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 5.64
ALMLB.PA Price Earnings VS Forward Price EarningsALMLB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALMLB is valued a bit more expensive than 72.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2986.2
ALMLB.PA Per share dataALMLB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALMLB's earnings are expected to decrease with -31.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.93%
EPS Next 3Y-31.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALMLB.PA Dividend Analysis

5.1 Amount

  • No dividends for ALMLB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALMLB.PA Fundamentals: All Metrics, Ratios and Statistics

MILIBOO SA

EPA:ALMLB (3/25/2026, 7:00:00 PM)

1.76

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.20M
Revenue(TTM)38.98M
Net Income(TTM)-257.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.64
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 1.87
P/tB 2.83
EV/EBITDA 2986.2
EPS(TTM)-0.04
EYN/A
EPS(NY)0.31
Fwd EY17.71%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS5.62
BVpS0.94
TBVpS0.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.61%
ROE -3.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.58%
FCFM N/A
ROA(3y)0.93%
ROA(5y)2.07%
ROE(3y)-1.09%
ROE(5y)23.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5Y1.16%
F-Score2
Asset Turnover2.45
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 236.75
Cap/Depr 162.09%
Cap/Sales 2.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.85
Altman-Z 3.47
F-Score2
WACC7.11%
ROIC/WACCN/A
Cap/Depr(3y)200.54%
Cap/Depr(5y)208.68%
Cap/Sales(3y)2.1%
Cap/Sales(5y)2.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-110.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.16%
EPS Next Y17.64%
EPS Next 2Y0.93%
EPS Next 3Y-31.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.02%
Revenue growth 3Y-0.18%
Revenue growth 5Y5.42%
Sales Q2Q%-7.29%
Revenue Next Year-8.57%
Revenue Next 2Y-6.23%
Revenue Next 3Y-8.53%
Revenue Next 5YN/A
EBIT growth 1Y-118.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.04%
EBIT Next 3Y-21.17%
EBIT Next 5YN/A
FCF growth 1Y-215.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.08%
OCF growth 3YN/A
OCF growth 5YN/A

MILIBOO SA / ALMLB.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MILIBOO SA (ALMLB.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALMLB.PA.


Can you provide the valuation status for MILIBOO SA?

ChartMill assigns a valuation rating of 4 / 10 to MILIBOO SA (ALMLB.PA). This can be considered as Fairly Valued.


How profitable is MILIBOO SA (ALMLB.PA) stock?

MILIBOO SA (ALMLB.PA) has a profitability rating of 1 / 10.


How financially healthy is MILIBOO SA?

The financial health rating of MILIBOO SA (ALMLB.PA) is 5 / 10.